Quality of life in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1477-7819

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Quality of life in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis ; volume:20 ; number:1 ; day:4 ; month:10 ; year:2022 ; pages:1-11 ; date:12.2022
World journal of surgical oncology ; 20, Heft 1 (4.10.2022), 1-11, 12.2022

Creator: Liu, Wei
Zhang, Qian
Zhang, Tiantian
Li, Li
Xu, Chunhua

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12957-022-02800-1

URN: urn:nbn:de:101:1-2022122408590978071841

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Liu, Wei
Zhang, Qian
Zhang, Tiantian
Li, Li
Xu, Chunhua
SpringerLink (Online service)

Other Objects (12)

Radiotherapy combined with anti-PD-1 and TKI for primary cardiac angiosarcoma considering the joint assessment of TLSs and PD-L1: a case report

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Online Particle Measurement in Clean Gas at the Beginning of Cake‐forming Dust Separation with Needled Felts in the Gas Cleaning

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

Radiotherapy combined with anti-PD-1 and TKI for primary cardiac angiosarcoma considering the joint assessment of TLSs and PD-L1: a case report

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Online Particle Measurement in Clean Gas at the Beginning of Cake‐forming Dust Separation with Needled Felts in the Gas Cleaning

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

Radiotherapy combined with anti-PD-1 and TKI for primary cardiac angiosarcoma considering the joint assessment of TLSs and PD-L1: a case report

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Online Particle Measurement in Clean Gas at the Beginning of Cake‐forming Dust Separation with Needled Felts in the Gas Cleaning

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Quality of life in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Radiotherapy combined with anti-PD-1 and TKI for primary cardiac angiosarcoma considering the joint assessment of TLSs and PD-L1: a case report

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Online Particle Measurement in Clean Gas at the Beginning of Cake‐forming Dust Separation with Needled Felts in the Gas Cleaning

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

Radiotherapy combined with anti-PD-1 and TKI for primary cardiac angiosarcoma considering the joint assessment of TLSs and PD-L1: a case report

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Online Particle Measurement in Clean Gas at the Beginning of Cake‐forming Dust Separation with Needled Felts in the Gas Cleaning

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

Radiotherapy combined with anti-PD-1 and TKI for primary cardiac angiosarcoma considering the joint assessment of TLSs and PD-L1: a case report

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Online Particle Measurement in Clean Gas at the Beginning of Cake‐forming Dust Separation with Needled Felts in the Gas Cleaning

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

Related objects

Reset password